Synonyms: GS-5885 | GS5885 | Harvoni® (ledipasvir + sofosbuvir)
ledipasvir is an approved drug (EMA & FDA (2014))
Compound class:
Synthetic organic
Comment: Ledipasvir is an orally available, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [1].
|
|
Bioactivity Comments |
Low dose GS-5885 monotherapy, delivered for 3 days, demonstrated significant antiviral activity in genotype 1a and 1b HCV-infected patients in an early Phase 1 study [1]. |